The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya
Recruiting
N/A
Interventional Study
Autism
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 24 Months – 72 Months
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 850 (estimated)
- Sponsor
- Indiana University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and uninfected (CHUU).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children enrolled in the Tabiri study (R01HD104552)
* CHEU or CHUU
* Children ages 24-72 months
* Caregivers of children must speak Kiswahili (local language) or English.
Exclusion Criteria:
* There will be no specific exclusion criteria. We anticipate that a small number of…
Contacts